Evaluation of an automated feedback intervention to improve antimicrobial prescribing among primary care physicians (OPEN Stewardship): protocol for an interrupted time-series and usability analysis in Ontario, Canada and Southern Israel.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
13 01 2021
Historique:
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 15 5 2021
Statut: epublish

Résumé

Antimicrobial resistance undermines our ability to treat bacterial infections, leading to longer hospital stays, increased morbidity and mortality, and a mounting burden to the healthcare system. Antimicrobial stewardship is increasingly important to safeguard the efficacy of existing drugs, as few new drugs are in the developmental pipeline. While significant progress has been made with respect to stewardship in hospitals, relatively little progress has been made in the primary care setting, where the majority of antimicrobials are prescribed. OPEN Stewardship is an international collaboration to develop an automated feedback platform to improve responsible antimicrobial prescribing among primary care physicians and capable of being deployed across heterogeneous healthcare settings. We describe the protocol for an evaluation of this automated feedback intervention with two main objectives: assessing changes in antimicrobial prescribing among participating physicians and determining the usability and usefulness of the reports. A non-randomised evaluation of the automated feedback intervention (OPEN Stewardship) will be conducted among approximately 150 primary care physicians recruited from Ontario, Canada and Southern Israel, based on a series of targeted stewardship messages sent using the platform. Using a controlled interrupted time-series analysis and multilevel negative binomial modelling, we will compare the antimicrobial prescribing rates of participants before and after the intervention, and also to the prescribing rates of non-participants (from the same healthcare network) during the same period. We will examine outcomes targeted by the stewardship messages, including prescribing for antimicrobials with duration longer than 7 days and prescribing for indications where antimicrobials are typically unnecessary. Participants will also complete a series of surveys to determine the usability and usefulness of the stewardship reports. All sites have obtained ethics committee approval to recruit providers and access anonymised prescribing data. Dissemination will occur through open-access publication, stakeholder networks and national/international meetings.

Identifiants

pubmed: 33441352
pii: bmjopen-2020-039810
doi: 10.1136/bmjopen-2020-039810
pmc: PMC7812099
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e039810

Subventions

Organisme : CIHR
ID : AMR-155212
Pays : Canada

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Fam Pract. 2000 May;49(5):407-14
pubmed: 10836770
Cochrane Database Syst Rev. 2017 Jun 19;6:CD000245
pubmed: 28626858
Curr Opin Infect Dis. 2011 Aug;24(4):357-62
pubmed: 21587070
JAMA. 2016 Feb 9;315(6):562-70
pubmed: 26864410
BMJ. 2019 Feb 27;364:l440
pubmed: 30814052
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
Can Fam Physician. 2018 Mar;64(3):168-169
pubmed: 29540377
Clin Microbiol Infect. 2017 Nov;23(11):793-798
pubmed: 28882725
JAMA. 2014 Dec 17;312(23):2569-70
pubmed: 25317759
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Implement Sci. 2014 Jun 19;9:77
pubmed: 24943919
Am J Manag Care. 2015 Oct 01;21(10):e567-75
pubmed: 26619058
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29967028
Expert Rev Anti Infect Ther. 2009 Dec;7(10):1175-83
pubmed: 19968511
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
BMJ. 2015 Jun 09;350:h2750
pubmed: 26058820
Antimicrob Resist Infect Control. 2019 Feb 12;8:35
pubmed: 30805182
Int J Pediatr Otorhinolaryngol. 2011 Dec;75(12):1496-501
pubmed: 21945244
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003539
pubmed: 16235325
Clin Infect Dis. 2009 Oct 15;49(8):1175-84
pubmed: 19739972
Lancet. 2013 Oct 5;382(9899):1175-82
pubmed: 23915885
CMAJ. 2007 Oct 9;177(8):877-83
pubmed: 17923655
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
MMWR Recomm Rep. 2016 Nov 11;65(6):1-12
pubmed: 27832047

Auteurs

Jean-Paul R Soucy (JR)

Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Marcelo Low (M)

Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.

Kamal Raj Acharya (KR)

Department of Population Medicine, University of Guelph Ontario Veterinary College, Guelph, Ontario, Canada.

Moriah Ellen (M)

Department of Health Services Management, Guilford Glazer Faculty of Business and Management, University of the Negev, Beer Sheva, Israel.

Anette Hulth (A)

The Public Health Agency of Sweden, Stockholm, Sweden.

Sonja Löfmark (S)

The Public Health Agency of Sweden, Stockholm, Sweden.

Gary E Garber (GE)

Infection Prevention and Control, Public Health Ontario, Toronto, Ontario, Canada.
Infectious Diseases, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

William Watson (W)

Department of Family & Community Medicine, University of Toronto, Toronto, Ontario, Canada.
St Michael's Hospital, Toronto, Ontario, Canada.

Jacob Moran-Gilad (J)

School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

David N Fisman (DN)

Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Derek R MacFadden (DR)

Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada dmacfadden@toh.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH